- Fee assured
- Verified this account
- Coronary angiography
- Fractional flow reserve (FFR)
- Interventional cardiology
I am a consultant cardiologist, working at the Royal Albert Edward Infirmary Wigan and Wythenshawe Hospital, Manchester. I specialise in Interventional cardiology. My special interests in addition to percutaneous coronary Intervention (angioplasty) are hypertension, atrial fibrillation, anti-platelet therapies.
I am a firm believer in right treatment, promptly, every time. Following my graduation and general medical training I undertook a period of research in Cardiovascular medicine in Birmingham towards a doctor of medicine (md) degree. I undertook my cardiology training in Mersey deanery and specialist training in interventional Cardiology at Liverpool Heart and Chest Hospital.
I joined the North Wales cardiac centre at Glan Clwyd Hospital in 2014 as a consultant in interventional cardiology and then moved to Wigan in mid 2017.
I have published articles and presented in national and international conferences on topics related to hypertension and coronary intervention. I am also the principal investigator of clinical trials in cardiology.
Areas of interest
Assessment and management of chest pain, breathlessness, palpitations; dizziness; blackouts;
Cardiac risk evaluation and modification;
Coronary Angiography and Angioplasty;
Angina and myocardial infarction;
Arrhythmias e.g. atrial fibrillation and flutter;
Hypertrophic and dilated cardiomyopathy;
Valvular heart disease;
Hypertension (high blood pressure);
Current NHS consultant posts held
Consultant, Interventional Cardiology
Royal Albert Edward Infirmary
Wrightington Wigan and Leigh NHS Foundation Trust, Wigan
Manchester University Hospitals NHS Foundation Trust
• Assessment and management of chest pain, breathlessness, palpitations and dizziness
• Cardiac risk evaluation and modification
• Coronary Angiography and Angioplasty
• Angina and myocardial infarction
• Arrhythmias e.g. atrial fibrillation and flutter
• Hypertrophic and dilated cardiomyopathy
• Valvular heart disease
• Hypertension (high blood pressure)
• Heart Failure
I am a keen runner, who discovered my running potential and have been successfully completing British 10k runs in recent years.
I have been raising money for charity for causes including restoring vision for the poor and educating young girls in India.
Young Investigators' Travel Grant, European Society of Cardiology, 2008, Vienna, Austria
I have over 32 publications. Following are a few as listed on PubMed:
1: Heseltine TD, Karthikeyan VJ, Morris J. Takotsubo cardiomyopathy with secondary coronary embolus. BMJ Case Rep. 2014 Apr 25;2014.
2: Krishnan U, Karthikeyan VJ, Trinh J, Theologou T, Velavan P. First report of the use of transesophageal echocardiography to position a temporary pacing wire.
J Cardiothorac Vasc Anesth. 2014 Feb;28(1):110-1.
3: Karthikeyan VJ, Krishnan U, Palmer ND. Right coronary artery spasm causing ventricular fibrillation and non-ST elevation myocardial infarction following
radial artery cannulation. Heart Asia. 2013 Jun 10;5(1):92-3.
4: Karthikeyan VJ, Lane DA, Beevers DG, Lip GY, Blann AD. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy
complications. J Hum Hypertens. 2013 Feb;27(2):72-8.
5: Karthikeyan VJ, Lip GY, Lane DA, Blann AD. Angiogenin and apoptosis in hypertension in pregnancy. Pregnancy Hypertens. 2011 Jul-Oct;1(3-4):191-6.
6: Karthikeyan VJ, Lip GY. Endothelial damage/dysfunction and hypertension in pregnancy. Front Biosci (Elite Ed). 2011 Jun 1;3:1100-8. Review.
7: Karthikeyan VJ, Lip GY, Baghdadi S, Lane DA, Beevers DG, Blann AD. Angiogenin and hemoxygenase in pregnancy: influence of hypertension. Angiology. 2012
8: Karthikeyan VJ, Lip GY, Baghdadi S, Lane DA, Beevers DG, Blann AD. Soluble Fas and Fas ligand in pregnancy: influence of hypertension. Angiology. 2012 Jan;63(1):35-8.
9: Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY. Endothelial dysfunction in hypertension in pregnancy: associations between
circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol. 2011 Jun;100(6):531-7.
10: Karthikeyan VJ, Ferner RE, Baghdadi S, Lane DA, Lip GY, Beevers DG. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. J Hypertens. 2011 Feb;29(2):396-9.
Courses offered to GPs
I take every opportunity to speak to GPs in the local area and have delivered didactic talks to GPs in the North West (Warrington) as well as in North Wales.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.http://www.bcis.org.uk
- MBBS Bangalore Medical College 1998
- MRCP (UK) Royal College of Physicians, London 2004
- Doctor of Medicine, MD (Cardiovascular Medicine) University of Birmingham 2012
- Fellow, European Society of Cardiology (FESC) European Society of Cardiology 2015
- Fellow (FRCP) Royal College of Physicians, London, UK 2017
Reference number 5207205
Professional bodies (positions held - last 3 yrs)
- Representative, North Wales New Consultants' Committee, Royal College of Physicians 2014
Details of entry to specialist register
- CCT Cardiology/ General Medicine, 2013
Affiliations / memberships
BCS; BCIS; ESC; EAPCI; ESC
- Spire Manchester
- 18:00 - 20:00
- 0161 447 6600
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details